Department of Microbiology and Molecular Genetics
Harvard Medical School
Home Research
Interests
Publications People Training
Opportunities
Useful
Links
Contact
Us

Publications

  1. Li J, Wang JT, Whelan SP. A unique strategy of mRNA cap methylation used by vesicular stomatitis virus. Proc Natl Acad Sci U S A 2006: 103 8493-8.
  2. Robinson C. D., Lourido S., Whelan S. P., Dudycha J. L., Lynch M., Isern S. Viral Transgenesis of Embryonic Cell Cultures from the Freshwater Microcrustacean Daphnia. J. Exp. Zool. 2006;305A:62-67.
  3. Schott D, Cureton DK, Whelan SP, Hunter C. An antiviral role for the RNA interference machinery in Caenorhabditis elegans. Proc Natl Acad Sci U S A 2005: 102(51):18420-18424.
  4. Li J, Fontaine-Rodriguez EC, Whelan SP. Amino acid residues within conserved domain VI of the vesicular stomatitis virus large polymerase protein essential for mRNA cap methyltransferase activity. J Virol. 2005;79(21):13373-84.
  5. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science. 2005;308(5728):1643-5.
  6. Cherry S, Doukas T, Armknecht S, Whelan S, Wang H, Sarnow P, Perrimon N. Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition. Genes Dev. 2005;19(4):445-52.
  7. Whelan SP, Barr JN, Wertz GW. Transcription and replication of nonsegmented negative-strand RNA viruses. Curr Top Microbiol Immunol. 2004;283:61-119.
  8. Barr JN, Whelan SP, Wertz GW. Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus. Biochim Biophys Acta. 2002;1577(2):337-53.
  9. Whelan SP, Wertz GW. Transcription and replication initiate at separate sites on the vesicular stomatitis virus genome. Proc Natl Acad Sci U S A. 2002;99(14):9178-83.
  10. Whelan SP, Barr JN, Wertz GW. Identification of a minimal size requirement for termination of vesicular stomatitis virus mRNA: implications for the mechanism of transcription. J Virol. 2000;74(18):8268-76.
  11. Whelan SP, Wertz GW. Regulation of RNA synthesis by the genomic termini of vesicular stomatitis virus: identification of distinct sequences essential for transcription but not replication. J Virol. 1999;73(1):297-306.
  12. Whelan SP, Wertz GW. The 5' terminal trailer region of vesicular stomatitis virus contains a position-dependent cis-acting signal for assembly of RNA into infectious particles. J Virol. 1999;73(1):307-15.
  13. Barr JN, Whelan SP, Wertz GW. cis-Acting signals involved in termination of vesicular stomatitis virus mRNA synthesis include the conserved AUAC and the U7 signal for polyadenylation. J Virol. 1997;71(11):8718-25.
  14. Barr JN, Whelan SP, Wertz GW. Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription. J Virol. 1997;71(3):1794-801.
  15. Whelan SP, Ball LA, Barr JN, Wertz GT. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci U S A. 1995;92(18):8388-92.
  16. Whelan SP, Evans D, Almond JW. Manipulation of the cellular binding properties of poliovirus: implications for non-target effects of recombinant vaccines. Dev Biol Stand. 1995;84:129-36.
  17. Wertz GW, Whelan S, LeGrone A, Ball LA. Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA. Proc Natl Acad Sci U S A. 1994;91(18):8587-91.